Skip to main content
Equibles

Christopher Gibson, Ph.D.

Chairman

Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (RXRX)

Equibles does not estimate personal net worth.

Get an email with a short summary when Recursion Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.

Get RXRX alerts

About Christopher Gibson, Ph.D.

Christopher Gibson, Ph.D. is recorded as Chairman at Recursion Pharmaceuticals, Inc. (RXRX) since January 1, 2026. Recursion Pharmaceuticals, Inc. reported in an 8-K filed November 5, 2025 that Christopher Gibson, Ph.D. was appointed Chair of the Board, effective January 1, 2026. Recursion Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Recursion Pharmaceuticals, Inc. includes Christopher C. Gibson (CEO and Board Member), Najat Khan (CEO), Najat Khan, Ph.D. (CEO and Board Member) and 7 others.

“On November 4, 2025, the Board of Directors (the "Board") of Recursion Pharmaceuticals, Inc. (the "Company") appointed Najat Khan, Ph.D., the Company's Chief Research and Development Officer and Chief Commercial Officer, as the Company's Chief Executive Officer and President, and appointed Christopher Gibson, Ph.D., the Company's Chief Executive Officer and President, as Chair of the Board, both effective as of January 1, 2026.”
Recursion Pharmaceuticals, Inc. Form 8-K, filed November 5, 2025 · Read the filing

Affiliation history

Company network

Leadership on record at Recursion Pharmaceuticals, Inc.

Recent activity